P Karlsson Selected Research

P Karlsson Research Topics

13	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2009
8	Neoplasms (Cancer) 10/2021 - 02/2010
3	Pain (Aches) 12/2020 - 11/2003
2	Neuralgia (Stump Neuralgia) 12/2020 - 01/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 09/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 03/2013
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 12/2020
1	Polyneuropathies (Polyneuropathy) 12/2020
1	Cerebral Palsy (Spastic Diplegia) 01/2017
1	Hyperalgesia 01/2017
1	Residual Neoplasm 01/2017
1	Ulcer 11/2003
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2002
1	Alzheimer Disease (Alzheimer's Disease) 03/2000
1	Melanoma (Melanoma, Malignant) 02/2000

2	Hormones (Hormone)IBA 01/2023 - 10/2021
2	NAD (NADH)IBA 12/2020 - 01/2019
2	Pain-FreeIBA 01/2017 - 09/2015
2	Estrogen ReceptorsIBA 10/2011 - 09/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2011 - 09/2011
2	Fluorouracil (Carac)FDA LinkGeneric 10/2011 - 09/2011
2	Goserelin (Zoladex)FDA Link 10/2011 - 02/2010
2	Methotrexate (Mexate)FDA LinkGeneric 10/2011 - 09/2011
2	Tamoxifen FDA LinkGeneric 09/2011 - 02/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Letrozole (Femara)FDA LinkGeneric 10/2021
1	Estrogens (Estrogen)FDA Link 10/2021
1	Capsaicin (Zostrix)FDA Link 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	Indicators and Reagents (Reagents)IBA 03/2013
1	naproxen-n-butyl nitrateIBA 11/2003
1	Naproxen (Naprosyn)FDA LinkGeneric 11/2003
1	vinpocetineIBA 12/2002
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 03/2000
1	1-azabicyclo(2.2.2)oct-3-yl 2- hydroxy- 2- (1- iodo- 1- propen- 3- yl)- 2- phenylacetateIBA 03/2000

7	Therapeutics 10/2018 - 02/2010
4	Drug Therapy (Chemotherapy) 01/2017 - 02/2010
3	Radiotherapy 11/2016 - 03/2013
3	Adjuvant Chemotherapy 10/2011 - 09/2009
1	Self-Help Devices (Assistive Technology) 01/2017
1	Lasers (Laser) 01/2017
1	Neoadjuvant Therapy 01/2017
1	Thoracotomy 01/2017
1	Segmental Mastectomy (Lumpectomy) 11/2016
1	Mastectomy (Mammectomy) 11/2012
1	Secondary Prevention 02/2000